healthcare

Winterflood's latest review

Biotech has fallen

It is hard to think of the 'positives' of an ageing population in the UK, writes Lawrence Gosling.

Tom Delic, assistant fund manager at Seneca Investment Managers explores the demographic trends - from opportunities in tech to wealth management - that are available for investors to take advantage of

Tough 12 months

The Merchants trust's Simon Gergel explains why investing in one of the UK's biggest healthcare stocks - GlaxoSmithKline - is not as simple as many investors envisage

Hardeep Tawakley takes a closer look at the evolution of specialist funds and speaks to buyers about their favourite offerings.

Rising rates also a boost

Equities already entered a bear market

Oil, industrials and banks dividends at risk